Information around the vaccination against the coronavirus SARS-CoV-2.
The most effective protection against one's own serious or even fatal illness with the coronavirus SARS-CoV-2, is the corona vaccination. In addition, each vaccination helps to contain the spread of the coronavirus, helping to protect the entire population.
This page provides information on eligibility and recommendation for vaccination, how to get a vaccination appointment, and the vaccination process.
To help you keep up to date with all the latest developments, this page will be updated regularly. Last updated on: June, 9th 2022
Who is entitled to a vaccine?
Anyone who lives or works in Germany or who is usually resident in Germany is entitled to get a Covid-19 vaccine, regardless of their insurance coverage. The vaccines for the basic immunisation and the booster vaccinations are free for these people. Currently the costs are being covered by the german government.
Based on regulations regarding the admission of the vaccines, that are available in Germany, people from the age of 5 can get vaccinated.
Vaccination recommendation and schedule
To be protected against a severe COVID-19 course, a complete basic immunization is required. According to the recommendations of the STIKO, vaccination is given according to the following schedule:
- 2 doses of Comirnaty (Biontech/Pfizer) at 3-6 week intervals or
- 2 doses of Spikevax (Moderna) at intervals of 4-6 weeks or
- 2 doses of Vaxzevria (AstraZeneca) at 9-12 week intervals or
- 2 doses of Nuvaxovid (Novavax) at 3 week intervals or
- 1 dose of Covid-19 Vaccine Janssen (Johnson & Johnson) followed by 1 dose of Comirnaty (Biontech/Pfizer) or Spikevax (Moderna) starting 4 weeks after the 1st dose
- 1 dose of Vaxzevria (AstraZeneca) followed by a dose of Comirnaty (Biontech/Pfizer) or Spikevax (Moderna) starting 4 weeks after the 1st dose.
If the period between the first and second dose of the vaccine is exceeded, the series of vaccinations should still be continued rather than started again from the first dose.
With regard to the use of the vaccines, the following STIKO recommendations currently apply:
- Comirnaty (Biontech/Pfizer): children from 5 years old (children between 5 and 11 years old with a pediatric dose, children and adolescents from 12 years old with an adult dose), unvaccinated pregnant and breastfeeding women regardless of age
- Spikevax (Moderna): persons from 30 years of age
- Nuvaxovid (Novavax): persons aged 18 and older
- Vaxzevria (AstraZeneca): persons 60 years and older
- Covid-19 Vaccine Janssen (Johnson & Johnson): Persons 60 years of age and older
Note: Individuals who have been fully vaccinated with the non-EU licensed vaccines CoronaVac from Sinovac, Covilo from Sinopharm, Covaxin from Bharat Biotech International Limited, or SputnikV from Gamelaya should undergo boosters with an mRNA vaccine 3 months after the last vaccine dose. They will then be considered fully vaccinated. However, those who have received only one vaccination dose with one of the above mentioned vaccines should receive a basic immunization and booster with a vaccine licensed in Germany.
Note on vaccinating children
Healthy children and adolescents aged 5 to 11 years should preferably be vaccinated with a single child dose of the Comirnaty vaccine from Biontech/Pfizer according to STIKO recommendations. The mRNA vaccine Spikevax from Moderna is also approved for children and adolescents aged 6 to 11 years.
For children and adolescents aged 5 to 11 years with previous disease or contact with high-risk groups, the STIKO recommends a double vaccination and a booster vaccination with the Comirnaty children's vaccine from Biontech/Pfizer. The mRNA vaccine Spikevax from Moderna is also approved for children and adolescents aged 6 to 11 years.
The mRNA vaccine Comirnaty from Biontech/Pfizer and the mRNA vaccine Spikevax from Moderna are approved in the EU for children aged 12 years and older. In Germany, however, only Comirnaty is used for vaccination of this group of people.
The STIKO recommends Corona vaccination with Comirnaty for all children and adolescents 12 to 17 years of age. Scientific data suggest that the benefits of vaccination outweigh the risk for severe vaccine side effects. Vaccination protects children and adolescents from COVID-19 and its associated psychosocial sequelae. Vaccination should be preceded by a physician's explanation of the benefits and risks.
Especially those children and adolescents who have an increased risk of severe Covid-19 due to pre-existing conditions can benefit from a Covid-19 vaccination. This includes children and adolescents with the following deseases:
- Congenital or acquired immunodeficiency or relevant immunosuppression
- congenital cyanotic heart defects
- severe heart failure
- severe pulmonary hypertension
- chronic pulmonary disease with persistent limitation of pulmonary function
- chronic renal insufficiency
- chronic neurological or neuromuscular diseases
- malignant tumor diseases
- trisomy 21
- syndromal diseases with severe impairment
- not optimally controlled diabetes mellitus
Children can now be vaccinated at immunization centers, as well as at the pediatrician's or family doctor's office. If you have any particular concerns or questions, it may be advisable for you to contact your child's pediatrician, as they know your child or their medical history best. He or she will be happy to advise you and also perform a risk-benefit assessment.
Note on vaccinating pregnant and breastfeeding women
Unvaccinated pregnant women from the 2nd trimester and unvaccinated breastfeeding women should receive Covid-19 vaccination with two doses of mRNA vaccine, preferably Cominaty. If pregnancy was established after the first vaccination, the second vaccination should not be administered until the 2nd trimester. Available study results on the safety of Corona vaccination during pregnancy or lactation do not show a clustered occurrence of undesirable side effects in mother and child.
If you have any particular concerns or questions, it may be advisable for you to contact your gynecologist or general practitioner, as they know you and your medical history best. He or she will be happy to advise you.
To whom is a booster vaccination recommended?
- The STIKO generally recommends booster vaccination for all persons over the age of 12. The recommendation also applies to pregnant women (from the 2nd trimester of pregnancy) and breastfeeding women. The STIKO also recommends a booster vaccination for children aged 5 - 11 years with a previous illness.
When should the booster vaccination take place?
- Ideally, the booster vaccination should be given from 3 months after the second vaccination dose. For booster vaccination of persons aged 18 years and older, the two mRNA vaccines Comirnaty (Biontech/Pfizer) and Spikevax (Moderna) are used in Germany*. Children and adolescents between 12 and 17 years of age should also receive a booster with Comirnaty (Biontech/Pfizer) within a time window of 3 to 6 months after the completed basic immunization. Children with a previous illness aged 5-11 years should receive the booster at an interval of ≥6 months after the completed basic immunization.
- Persons vaccinated once with Covid-19 Vaccine Janssen (Johnson&Johnson) should receive a second dose with an mRNA vaccine starting as early as four weeks after vaccination. They also should receive a booster vaccination with an mRNA vaccine Comirnaty from (Biontech/Pfizer) or Spikevax (Moderna) three months apart from the second dose of vaccine.
*Nuvaxovid has not yet been approved for booster vaccination, but may still be used for booster vaccination in persons 18 years of age and older if contraindicated to mRNA vaccines.
If you have any particular concerns or questions, it may be advisable for you to contact your general practitioner. He or she will advise you the best regarding the booster vaccination.
2nd booster vaccination
The STIKO recommends a 2nd booster vaccination for: people 70 years of age and older, residents and persons cared for in nursing facilities, people with immunodeficiency from 5 years of age and people working in medical facilities and nursing homes (especially in direct contact with patients and residents).
The 2nd booster vaccination should be given at the earliest 3 months after the 1st booster vaccination with an mRNA vaccine in groups of people at risk of health problems. Personnel in medical and nursing facilities should receive the 2nd booster vaccination after 6 months at the earliest.
Individuals in the above groups who have experienced a SARS-CoV-2 infection after the 1st booster vaccination are not recommended to receive another booster vaccination.
How you will receive your Covid-19 vaccination
Currently, the vaccination can be claimed in most medical practices and private doctors. Vaccination is also offered by company physicians in some cases. In addition, qualified pharmacists may also vaccinate against COVID-19. You can find participating pharmacies in your area here https://www.mein-apothekenmanager.de/ .
Persons in nursing facilities and homes are mainly vaccinated against COVID-19 by mobile vaccination teams. Persons who are not mobile and live at home can also be vaccinated by their local family doctor.
You can find out where there are vaccination facilities and vaccination campaigns in your federal state on the homepage of the federal government. There you will also find state-specific regulations regarding the Corona vaccination.
Note: Nursing facilities coordinate Corona vaccination within the facility with the agencies responsible in the federal states with the help of mobile vaccination teams. Corona vaccination via the company physician is coordinated by each company itself. Your employer will approach you should vaccination be offered in your company.
You must bring the following documents with you for your Covid-19 vaccination:
- Personal ID card or other photo ID to prove your age
- Vaccination record
- Any other medical documents you may have, e.g. heart disease card, diabetic card, list of medication
- Vaccination advice and explanation of the benefits of immunisation, side effects, start and duration of protection, advice on subsequent and booster vaccinations, recommendations on precautions to be taken post-vaccination.
- Examination of symptoms and establishment of medical history to rule out any illnesses and allergies
- Administration of vaccine
- Follow-up observation for any potential reaction to the vaccine
- Issue of vaccine documentation
Find out more:
- Information leaflets, medical history and consent forms for Covid-19 vaccinations are available in various languages from the Robert Koch Institute
- General information on the coronavirus in Germany (e.g. hygiene recommendations, information on financial aid, travel and coronavirus testing on return from travel)